PDD Holdings Inc. American Depositary Shares vs GeneDx Holdings Corp — how do they compare? PDD Holdings Inc. American Depositary Shares trades at $79.11 (market cap $111.74B), while GeneDx Holdings Corp trades at $67.73 (market cap $2.04B). The key difference: PDD Holdings Inc. American Depositary Shares is far larger — about 54.8× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, PDD Holdings Inc. American Depositary Shares nearer its low. Which is the better fit depends on your goals.
| PDD | WGS | |
|---|---|---|
Market Cap | $111.74B | $2.04B |
Volume | 4,029,869 | 659,215 |
Sector | Consumer Cyclical | Health |
52-Week High | $138.13 | $167.51 |
52-Week Low | $73.30 | $34.51 |
Enterprise Value | $44.39B | $2.08B |
Typical Hold Time | — | 19 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx (WGS) trades at $68.53, down 4.18% today amid bearish technical signals despite recent positive earnings surprises. The stock shows mixed fundamentals with strong revenue growth to $454M in 2026 but negative profitability metrics including -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target representing 18% upside potential.
The investment case balances strong analyst support and genomic testing market growth against persistent profitability challenges and negative cash flow trends. Key catalysts include Q3 2026 earnings due soon and continued execution on operational improvements, while risks center on margin recovery timeline and competitive pressures in the rapidly evolving genomics space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
PDD Holdings is a multinational commerce group that owns and operates a portfolio of businesses. Its sourcing, logistics, and fulfillment network supports those businesses and their commerce operations.
Read more on PDD →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →